Patents/Inventors

Pingda Ren

San Diego, CAUS25 patents

25 Patents

US126065722026
Substituted Heterocycles and Uses Thereof
Kumquat Biosciences Inc.
0 cites
US125515552026
Compositions and Methods for Potentiating Immune Activity
Kumquat Biosciences Inc.
0 cites
US125034642025
1,2,5-thiadiazolidin-3-one 1,1-dioxide Containing Compounds and Uses Thereof
Kumquat Biosciences Inc.
0 cites
USRE0505272025
Covalent Inhibitors of KRAS G12C
Araxes Pharma LLC
0 cites
US123656762025
Heterocyclic Compounds and Uses Thereof
Kumquat Biosciences Inc.
0 cites
USRE0504902025
Substituted Quinazoline Compounds and Methods of Use Thereof
Araxes Pharma LLC
0 cites
US122864272025
Heterocyclic Compounds and Uses Thereof
Kumquat Biosciences Inc.
0 cites
US122342442025
Substituted Piperazines as Inhibitors of KRAS G12C
Araxes Pharma LLC
0 cites
US122091022025
Heterocyclic Compounds and Uses Thereof
Kumquat Biosciences Inc.
0 cites
US121954652025
Macrocyclic Heterocycles and Uses Thereof
Kumquat Biosciences Inc.
0 cites
US121346202024
Heterocyclic Spiro Compounds and Methods of Use Thereof for the Treatment of Cancer
ARAXES PHARMA LLC
0 cites
US120594252024
Heterocyclic Compounds and Uses Thereof
Kumquat Biosciences Inc.
0 cites
US120180112024
Macrocyclic Compounds and Compositions, and Methods of Preparing and Using the Same
Kura Oncology, Inc.
0 cites
US119446272024
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
KURA ONCOLOGY, Inc.
0 cites
US119127082024
Macrocyclic Heterocycles and Uses Thereof
KUMQUAT BIOSCIENCES Inc.
0 cites
US118789852024
Substituted Quinazolines as Inhibitors of KRAS G12C
Araxes Pharma LLC
0 cites
USRE0496872023
Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof
KURA ONCOLOGY, Inc.
0 cites
US116738982023
Substituted Inhibitors of Menin-mll and Methods of Use
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
0 cites
US116482542023
Substituted Pyrido[2,3-d]pyrimidines as Inhibitors of Ras Pathway Signaling
Kumquat Biosciences Inc.
0 cites
US116492512023
Substituted Inhibitors of Menin-mll and Methods of Use
KURA ONCOLOGY, Inc.
0 cites
US116393462023
Quinazoline Derivatives as Modulators of Mutant KRAS, HRAS or NRAS
ARAXES PHARMA LLC
0 cites
US115550412023
Bridged Bicyclic Inhibitors of Menin-mll and Methods of Use
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
0 cites
US115476972023
Heterocyclic Compounds and Uses Thereof
MILLENNIUM PHARMACEUTICALS, Inc.
0 cites
US115422442023
Synthesis of Tipifarnib
KURA ONCOLOGY, Inc.
0 cites
US115422482023
Methods and Compositions for Inhibiting the Interaction of Menin with MLL Proteins
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
0 cites